As Seen In

As Seen In
Cell Therapy Group Interview with CEO, David Hall
Despite us both living in the Vancouver area and both being involved in cell therapy,...
As Seen In
RepliCel Life Sciences Inc. (TSXV: RP) Seeks to Heal with Patients Own Cells
 FINANCIAL POST ARTICLE PUBLISHED ON FEBRUARY 25, 2014Imagine using healthy cells from your body to...
As Seen In
Vancouver hair-loss biotech wins Japanese patent
BUSINESS IN VANCOUVER ARTICLE PUBLISHED ON JANUARY 13, 2014 Vancouver-based RepliCel Life Sciences Inc., a...
As Seen In
A cure for baldness? Stem cell researchers race to regenerate follicles from hair resistant to loss
The cure for baldness? It could be closer than you think — i.e. among the...
As Seen In
Stem Cell Technology Used in Search for the Holy Grail of Hair Treatments: a Cure for Baldness
Hisae Nakamura, director of research and development for RepliCel, with a device used to inject...
As Seen In
Vancouver Biotech Receives U.S. Patent for Hair Regeneration Technology
By Emma Crawford, Thu Apr 18, 2013 10:53am PSTVancouver biotech RepliCel Life Sciences Inc. (OTCQB:REPCF)(CNSX:RP)...
As Seen In
Chief Scientist Dr. Kevin McElwee Interviewed In Barcelona Article at Eldiariomontanes.es
 (English Translation)Injected hair stem cells are emerging as the most effective therapy against baldness
 EFE...
As Seen In
Chief Scientist Dr. Kevin McElwee Interviewed In Barcelona Article at Hazteoir.org
(English Translation) HAZTEOIR.ORG 
The website of the active citizen June 22, 2012 The patient’s own...
As Seen In
Ask Men features an interview with RepliCel Life Sciences CEO David Hall
 AskMen.comMen And Balding By Jeremy Berger, February 6, 2012The plague that has dogged us for...
As Seen In
September 11th Episode of The Bald Truth featuring RepliCel Life Sciences
To watch the September 11th episode of The Bald Truth, click here: http://www.youtube.com/watch?v=N8yO96ANRYc ...

DISCLAIMER:
The information in these press releases is historical in nature, has not been updated, and is current only to the date indicated in the particular press release. This information may no longer be accurate and therefore you should not rely on the information contained in these press releases. To the extent permitted by law, RepliCel Life Sciences Inc. and its employees, agents and consultants exclude all liability for any loss or damage arising from the use of, or reliance on, any such information, whether or not caused by any negligent act or omission.

THIRD PARTY CONTENT
Please note that any opinion, estimates or forecasts made by the authors of these statements are theirs alone and do not represent opinions, forecasts or predictions of RepliCel Life Sciences Inc. or its management. RepliCel Life Sciences Inc. does not, by its reference or distribution of these links imply its endorsement of, or concurrence with, such information, conclusions or recommendations.